• 1
    Bikle DD 2001 Osteoporosis in gastrointestinal, pancreatic, and hepatic diseases. In: MarcusR, FeldmanD, KelseyJ (eds.) Osteoporosis, 2nd ed. Academic Press, San Diego, CA, USA, 237258.
  • 2
    Hoenderop JGJ, Nilius B, Bindels RJM 2005 Calcium absorption across epithelia. Physiol Rev 85: 373422.
  • 3
    Mawer EB, Davies M 2005 Vitamin D nutrition and bone disease in adults. Rev Endocr Metab Disord 2: 153164.
  • 4
    Hollander D, Muralidhara KS, Zimmerman A 1978 Vitamin D3 intestinal absorption in vivo: Influence of fatty acids, bile salts, and perfusate pH on absorption. Gut 19: 267272.
  • 5
    Thompson GR, Lewis B, Booth CC 1966 Absorption of vitamin D3-3H in control subjects and patients with intestinal malabsorption. J Clin Invest 45: 94102.
  • 6
    Bernstein CN, Leslie WD 2003 The pathophysiology of bone disease in gastrointestinal disease. Eur J Gastroenterol Hepatol 15: 857864.
  • 7
    Von Tirpitz C, Reinshagen M 2003 Management of osteoporosis in patients with gastrointestinal diseases. Eur J Gastroenterol Hepatol 15: 869876.
  • 8
    Armagan O, Uz T, Tascioglu F, Colak O, Oner C, Akgun Y 2005 Serological screening for celiac disease in premenopausal women with idiopathic osteoporosis. Clin Rheumatol 24: 239243.
  • 9
    Abreu MT, Kantorovich V, Vasiliauskas EA, Gruntmanis U, Matuk R, Daigle K, Chen S, Zehnder D, Lin YC, Yang H, Hewison M, Adams JS 2004 Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn's patients with elevated 1,25-dihydroxymitamin D and low bone mineral density. Gut 53: 11291136.
  • 10
    Froicu M, Weaver V, Wynn TA, McDowell MA, Welsh JE, Cantorna MT 2003 A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol Endocrinol 17: 23862392.
  • 11
    Cannizzo F Jr, Kral JG 1998 Obesity surgery: A model of programmed undernutrition. Curr Opin Clin Nutr Metab Care 1: 363368.
  • 12
    Carlin AM, Rao DS, Meslemani AM, Genaw JA, Parikh NH, Levy S, Bhan A, Talpos GB 2006 Prevalence of vitamin D depletion among morbidly obese patients seeking gastric bypass surgery. Surg Obes Relat Dis 2: 98103.
  • 13
    Newbury L, Dolan K, Hatzifotis M, Low N, Fielding G 2003 Calcium and vitamin D depletion and elevated parathyroid hormone following biliopancreatic diversion. Obes Surg 13: 893895.
  • 14
    Coates PS, Fernstrom JD, Fernstrom MH, Schauer PR, Greenspan SL 2004 Gastric bypass surgery for morbid obesity leads to an increase in bone turnover and a decrease in bone mass. J Clin Endocrinol Metab 89: 10611065.
  • 15
    Levy C, Lindor KD 2003 Management of osteoporosis, fat-soluble vitamin deficiencies, and hyperlipidemia in primary biliary cirrhosis. Clin Liver Dis 7: 901910.
  • 16
    Duarte MP, Farias ML, Coelho HS, Mendonca LM, Stabnov LM, Docarmod-Oliveira M, Lamy RA, Oliveira DS 2001 Calcium-parathyroid hormone-vitamin D axis and metabolic bone disease in chronic viral liver disease. J Gastroenterol Hepatol 16: 10221027.
  • 17
    Hawkins FG, Leon M, Lopez MB, Valero MA, Larrodera L, Garcia-Garcia I, Loinaz C, Moreno-Gonzalez E 1994 Bone loss and turnover in patients with liver transplantation. Hepatogastroenterology 41: 158161.
  • 18
    Vedi S, Greer S, Skingle SJ, Garrahan NJ, Ninkovic M, Alexander GA, Compston JE 1999 Mechanism of bone loss after liver transplantation: A histomorphometric analysis. J Bone Miner Res 14: 281287.